echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Molecular Cancer: Austrian researchers discover drivers of prostate cancer metastasis

    Molecular Cancer: Austrian researchers discover drivers of prostate cancer metastasis

    • Last Update: 2022-04-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Prostate cancer is the second most common malignancy in men worldwide and is projected to surpass lung cancer in incidence over the next decade


    Researchers at the Medical University of Vienna (MedUni Vienna) in Austria have discovered a specific change in a protein


    In this study, the researchers explored the role of the KMT2C protein in prostate cancer


    The researchers from the Medical University of Vienna first analyzed the effect of Kmt2c SET domain deletion using a mouse model of prostate cancer, and then analyzed the effect of KMT2C truncating mutations in a large number of prostate cancer patients


    We therefore identified a truncation event of KMT2C as a driver of cell proliferation and prostate intraepithelial neoplasia (PIN) formation


    "Our study contributes to understanding the transition from localized to advanced metastatic prostate cancer," says corresponding author Lukas Kenner, from the Department of Pathology at the Medical University of Vienna


    KMT2C mutation status can be determined by blood tests, which promises to enable early diagnosis of aggressive prostate cancer progression


    The MYC inhibitor is essentially a new type of cancer treatment that is already being tested in clinical trials and has the potential to be used in metastatic prostate cancer in the coming years if further research confirms this


    Original text retrieval

    Limberger, T.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.